– Investor & analyst webcast, including a key opinion leader panel, to be held Monday, November 18th at 7:30 a.m. EST REDWOOD CITY, Calif., Nov. 15, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy to preserve sight for life in highly prevalent ocular diseases, plans to host a webcast to report 52-week LUNA phase 2 clinical data and 4-year OPTIC clinical data, and to provide key pivotal program design elements Monday, November ...

NEW YORK, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Luna Innovation, Inc. (NASDAQ: LUNA) on behalf of long-term stockholders following a class action complaint that was filed against Luna Innovation on April 1, 2024 with a Class Period from August 11, 2023 to March 25, 2024. Our investigation concerns whether the board of directors of Luna Innovation have breached their fiduciary duties to th ...

- Open for Sale Today, the Sister Ship to Norwegian Aqua™, Will Debut in March 2026 with Seven-Day Caribbean Voyages from the Cruise Capital of the World – Miami - - Norwegian Luna™ will 'Shine Brighter' with Celestial Hull Art Inspired by the Reflection of Moonlight on the Sea by Celebrated Street Artist – ELLE - MIAMI, Sept. 18, 2024 /PRNewswire/ -- Norwegian Cruise Line® (NCL), the innovator in global cruise travel, today unveiled and opened for sale the next evolution of its Prima Plus Class, the all-ne ...

-   6E10 combined with local prophylaxis selected for Phase 3 pivotal trials, with a favorable safety profile and potential best-in-class product profile at 26 weeks -   Efficacy: 76% of 6E10 patients were injection free, with maintained visual acuity and fluid control -   Safety: 100% of 6E10 difluprednate-alone patients had no or minimal inflammation, and none received corticosteroids for treatment of inflammation beyond the scheduled prophylaxis -   Patient Preference Survey: 88% of patients indicated a ...

SAN DIEGO, June 28, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors it is investigating the officers and directors of Luna Innovations Incorporated (NASDAQ:LUNA) to determine whether they violated securities laws and breached their fiduciary duties to shareholders in connection with financial reporting. Luna Innovations is a technology company that focuses on fiber optics. It creates products targeted towards the aerospace, automotive, and communications industries, among others. What Now: Luna Innov ...

SAN DIEGO, June 28, 2024 (GLOBE NEWSWIRE) -- Robbins LLP informs investors it is investigating the officers and directors of Luna Innovations Incorporated (NASDAQ: LUNA) to determine whether they violated securities laws and breached their fiduciary duties to shareholders in connection with financial reporting. Luna Innovations is a technology company that focuses on fiber optics. It creates products targeted towards the aerospace, automotive, and communications industries, among others. What Now: Luna Inno ...

NEW YORK, May 30, 2024 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Luna Innovations Incorporated ("Luna Innovations" or the "Company") (NASDAQ: LUNA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Luna Innovations investors who were adversely affected by alleged securities fraud between May 16, 2022 and April 19, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/luna- ...

NEW YORK, May 29, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Luna Innovations Incorporated (NASDAQ: LUNA).Shareholders who purchased shares of LUNA during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/luna-innovations-loss-submission-form/?id=81714&from=4CLASS PERIOD: May 16, ...

PHILADELPHIA, May 28, 2024 /PRNewswire/ -- Attention Luna Innovations Incorporated ("Luna Innovations" or the "Company") (NASDAQ: LUNA) Investors. A securities fraud class action lawsuit has been filed against Luna Innovations on behalf of purchasers of Luna Innovations securities between May 16, 2022 and April 19, 2024, inclusive (the "Class Period").CLICK HERE to learn more about the lawsuit.Important deadline: Investors who purchased or acquired Luna Innovations securities during the Class Period may, no ...

NEW YORK, May 22, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Luna Innovations Incorporated ("Luna" or the "Company") (NASDAQ: LUNA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.The class action concerns whether Luna and certain of its offic ...